Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Pharm-Olam Releases Updated Paper on the Impact of COVID on Clinical Research

Earlier this year, Pharm-Olam partnered with Informa’s Pharma Intelligence to draft a white paper that discusses the...

(1 minute read)

Tags: Infectious Disease & Vaccines, COVID-19, Global Coverage

Brexit is here - Is your clinical trial-ready?

The United Kingdom officially withdrew from the European Union (EU) on Jan 31, 2020. They have until Dec 31, 2020 to complete...

(3 minute read)

Tags: Pharm-Olam Insights, Global Coverage

The Benefits of Conducting Clinical Research in Russia

Pharm-Olam, as a global CRO, has over 20 years' experience conducting clinical trials in Central and Eastern Europe (CEE). In...

(4 minute read)

Tags: Pharm-Olam Insights, Global Coverage

Conducting Clinical Trials in South Africa: A Revitalized Environment

South Africa was once a commonly considered country for inclusion in clinical research, but its popularity caused bottlenecks...

(4 minute read)

Tags: Pharm-Olam Insights, Global Coverage

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.